Nautilus Capital
ir@nautiluscapital.com
The nexus of institutional macro strategy and cross-asset execution.
High-conviction analysis for the sophisticated allocator.
BlackRock’s ETHA has surpasssed $10 billion in AUM, fueled by institutional demand and the GENIUS Act. With rising global liquidity and a potential move to $16,000, we analyze why Ethereum is the decade's biggest trade.
Fundstrat’s GRNY ETF combines a top-down fundamental research framework with a quantitative, bottom-up stock selection process. We dive into the seven core themes driving its massive outperformance against the S&P 500.
Peloton has transformed from a volatile, hardware-driven business into a durable, profitable subscription model. We deconstruct the $55 habit with software-like margins.
Viking Therapeutics is emerging as a top contender in the trillion-dollar obesity market. With superior Phase 2 data for its oral pill VK2735 and strong buyout potential, we explore why this biotech is deeply undervalued.